Sign in

CIK 0001728328

  • Emerging growth company

InMed Pharmaceuticals Inc.

Sign in to watch
Ticker
MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 604-669-7207
Business address
C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
  1. 8-K Event Material agreement · Acquisition or sale completed · Results of operations · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change
  2. 4 Open-market buy 10% owner bought 2,640 shares at $13.10 ($34,572)
  3. 8-K Event Regulation FD disclosure
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Bylaws or fiscal year change · Shareholder vote results · Other events
  6. 8-K Event Regulation FD disclosure
  7. 10-Q Report Quarterly Report
  8. 425 Deal Prospectus/Communication re Business Combination
  9. 424B3 Offering Prospectus
  10. 4 Open-market buy 10% owner bought 4 shares at $1.32 ($5)
  11. 425 Deal Prospectus/Communication re Business Combination
  12. 4 Open-market buy 10% owner bought 1,087 shares at $1.32 ($1,435)
  13. 4 Open-market buy 10% owner bought 9,569 shares at an average $1.33 ($12,719)
  14. 4 Open-market buy 10% owner bought 10,903 shares at an average $1.33 ($14,484)
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 4 Open-market buy 10% owner bought 42,920 shares at an average $1.33 ($57,080)
  17. EFFECT Other Notice of Effectiveness
  18. 424B3 Offering Prospectus
  19. S-4/A Deal Registration Statement - Business Combination
  20. 8-K Event Delisting notice · Other events

Page 2 of 27 · 537 filings